您的位置: 首页 > 农业专利 > 详情页

Monoclonal anti-GT 468 antibodies for treatment of cancer
专利权人:
Ganymed Pharmaceuticals AG;Johannes Gutenberg-Universität Mainz
发明人:
Ugur Sahin,Ozlem Tureci,Michael Koslowski,Rita Mitnacht-Kraus
申请号:
US14977325
公开号:
US10596256B2
申请日:
2015.12.21
申请国别(地区):
US
年份:
2020
代理人:
摘要:
The present invention provides antibodies useful as therapeutics for treating and/or preventing diseases associated with cells expressing GT468, including tumor-related diseases such as breast cancer, lung cancer, gastric cancer, ovarian cancer, hepatocellular cancer, colon cancer, pancreatic cancer, esophageal cancer, head &; neck cancer, kidney cancer, in particular renal cell carcinoma, prostate cancer, liver cancer, melanoma, sarcoma, myeloma, neuroblastoma, placental choriocarcinoma, cervical cancer, and thyroid cancer, and the metastatic forms thereof. In one embodiment, the tumor disease is metastatic cancer in the lung.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充